Human papillomavirus
Human papillomavirus has been studied in 9 papers since 2016: 4 observational studies in people, 1 in cells, 2 reviews; 4 in the past year. The newest paper, Oct 10, 2026: “Predicting outcomes in oncogenic HPV infection: are we there yet?”.
9 papers study it7 findingsUpdated
1 new paper in 30 daysSee all 9 papers on human papillomavirus
At a glance
The findings reach people, from one lab or study. 4 independent labs in 3 countries.
“In this age bracket, the prevalence rate of any HPV genotype was found to be 19.27%.”
None of its findings points the other way.
- 4 independent labs in 3 countries
- Funders: National Cancer Institute and others
- 2 of 7 findings with company ties
- Humans4
- Cells1
- In silico2
What did studies of human papillomavirus find?
4Studies of human papillomavirus measured 4 outcomes, among them years of potential productive life lost, mortality and malignant transformation.
Years of potential productive life lost
upin humans1
1 study
Years of potential productive life lost
upin humans1
Human papillomavirus is linked with higher years of potential productive life lost in humans (2023 vs 2011) (43.9% higher in Brazil, 26.7% higher in Mexico).
Humans2023 vs 2011
Mortality
upin humans1+45%
1 study
Mortality
upin humans1+45%
Human papillomavirus is linked with higher mortality in humans (2023 vs 2011) (+44.6%).
Humans2023 vs 2011Brazil
Malignant transformation
upin human cells1
1 study
Malignant transformation
upin human cells1
Human papillomavirus induces malignant transformation in human cells.
Cellsfallopian tube
Cellular senescence
downin human cells1
1 study
Cellular senescence
downin human cells1
Human papillomavirus prevents cellular senescence in human cells.
Cellsfallopian tube
What is human papillomavirus linked with?
3Studies link human papillomavirus with 3 measures: cancer, cervical cancer and human papillomavirus infection.
Cancer
upin humans1
1 study
Cancer
upin humans1
Human papillomavirus is linked with a higher risk of cancer in humans (750 000 (PAF 4%)).
Humans
Cervical cancer
upin humans1+16%
1 study
Cervical cancer
upin humans1+16%
Human papillomavirus is associated with cervical cancer in humans (HPV-positive) (16.47%).
HumansHPV-positivefemales
Human papillomavirus infection
upin humans1+19%
1 study
Human papillomavirus infection
upin humans1+19%
Human papillomavirus is associated with human papillomavirus infection in humans (19.27%).
Humansfemales
Funding
13 grants since 2016National Cancer Institute$3.8MNational Institute of Dental and Craniofacial Research$1.7MNational Institute of Nursing Research$67.2K
National Cancer InstituteUniversity of Washington$98.7K2024–2029
National Institute of Dental and Craniofacial ResearchUniversity of Maryland Baltimore$562K2024–2029
National Cancer InstituteBeth Israel Deaconess Medical Center$256K2022–2027
Human papillomavirus mRNA detection for assessing cervical cancer risk in resource-limited settings
National Cancer InstituteRice University$50.5K2024–2025
Validating the Use of Point-Of-Care Diagnostics for Early Detection of Human Papillomavirus
Engineering and Physical Sciences Research CouncilUniversity of Nottingham£166K2024–2026
Swiss National Science Foundation2022–2024
National Cancer InstituteUniversity of British Columbia$286K2018–2024
Factors Associated with Mailed Return of Self-Sampling for Human Papillomavirus (HPV) Testing
National Institute of Nursing ResearchIndiana University Indianapolis$2.5K2019–2021
National Cancer InstitutePurdue University$71.8K2019–2024
Point-of-sampling detection of Human Papillomavirus (HPV)
National Institute of Allergy and Infectious DiseasesFoundation for Applied Molecular Evolutn$185K2018–2021
Contains public sector information licensed under the Open Government Licence v3.0.